Daily as of 3 Nov 16:00 ET
- Price
- below both $13.86 vs 50 $14.52 / 200 $14.37
- Projection
- 💀Death cross projected in 2 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 14 Mar 2024 · projected 24 bars out
TRVI | Trevi TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$13.86
+$0.23 (+1.69%)
Trevi Therapeutics (TRVI) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
Right now the daily is the chart to watch. The 50 SMA sits above the 200, but the two have been closing on each other and a death cross is projected within 10 bars. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $13.56 vs 50 $13.99 / 200 $6.36
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 29 Jul 2024 · projected 16 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $13.86 vs 50 $13.10 / 200 $16.17
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 24 Sep 2026 · projected 25 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 24 Sep 2026 | 💀Death | 4-hour | 25 bars out | Not tested |
| 14 Apr 2026 | 🟨Golden | 4-hour | 1 bar out | Not tested |
| 13 Apr 2026 | 💀Death | 4-hour | not projected | Not tested |
| 6 Apr 2026 | 🟨Golden | 4-hour | not projected | 1 bar cross test |
| 6 Feb 2026 | 💀Death | 4-hour | 28 bars out | 5 bar cross test |
About TRVI
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$23.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmid